LeMaitre Vascular (LMAT) News Today → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free LMAT Stock Alerts $78.45 +0.77 (+0.99%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13, 2024 | marketbeat.comSummit Creek Advisors LLC Raises Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Summit Creek Advisors LLC increased its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 37.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 228,501 shares of the medical instruments supplier's stocMay 13, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Hits New 12-Month High at $76.26LeMaitre Vascular (NASDAQ:LMAT) Reaches New 52-Week High at $76.26May 13, 2024 | marketbeat.comLeMaitre Vascular, Inc. to Issue Quarterly Dividend of $0.16 (NASDAQ:LMAT)LeMaitre Vascular, Inc. (NASDAQ:LMAT) declared a quarterly dividend on Tuesday, April 30th. Stockholders of record on Thursday, May 16th will be given a dividend of 0.16 per share by the medical instruments supplier on Thursday, May 30th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.84%. The ex-dividend date is Wednesday, May 15th.May 12, 2024 | americanbankingnews.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Recommendation of "Moderate Buy" from AnalystsMay 11, 2024 | marketbeat.comMesirow Institutional Investment Management Inc. Acquires Shares of 155,682 LeMaitre Vascular, Inc. (NASDAQ:LMAT)Mesirow Institutional Investment Management Inc. bought a new position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 155,682 shares of the medicalMay 11, 2024 | finance.yahoo.comWhy You Might Be Interested In LeMaitre Vascular, Inc. (NASDAQ:LMAT) For Its Upcoming DividendMay 11, 2024 | americanbankingnews.comLeMaitre Vascular (NASDAQ:LMAT) Rating Lowered to Hold at StockNews.comMay 10, 2024 | americanbankingnews.comGeorge W. Lemaitre Sells 8,000 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) StockMay 10, 2024 | americanbankingnews.comDavid B. Roberts Sells 5,025 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) StockMay 10, 2024 | americanbankingnews.comGeorge W. Lemaitre Sells 68,906 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) StockMay 9, 2024 | insidertrades.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Director David B. Roberts Sells 5,025 SharesMay 8, 2024 | marketbeat.comInsider Selling: LeMaitre Vascular, Inc. (NASDAQ:LMAT) Director Sells 5,025 Shares of StockLeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) Director David B. Roberts sold 5,025 shares of LeMaitre Vascular stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $75.62, for a total value of $379,990.50. Following the completion of the sale, the director now directly owns 14,114 shares in the company, valued at approximately $1,067,300.68. The sale was disclosed in a legal filing with the SEC, which is available at this link.May 6, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Reaches New 12-Month High After Analyst UpgradeLeMaitre Vascular (NASDAQ:LMAT) Hits New 1-Year High on Analyst UpgradeMay 5, 2024 | finance.yahoo.comLeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their PredictionsMay 4, 2024 | finance.yahoo.comLeMaitre Vascular First Quarter 2024 Earnings: Beats ExpectationsMay 4, 2024 | marketbeat.comRussell Investments Group Ltd. Has $16.36 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Russell Investments Group Ltd. raised its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 6.7% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 288,212 shares of the medical instruments supplier's stock after acquiring anMay 4, 2024 | finanznachrichten.deLeMaitre Vascular, Inc.: LeMaitre Q1 2024 Financial ResultsMay 3, 2024 | marketbeat.comStockNews.com Upgrades LeMaitre Vascular (NASDAQ:LMAT) to BuyStockNews.com raised LeMaitre Vascular from a "hold" rating to a "buy" rating in a research note on Friday.May 3, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Posts Quarterly Earnings Results, Beats Estimates By $0.05 EPSLeMaitre Vascular (NASDAQ:LMAT - Get Free Report) issued its earnings results on Thursday. The medical instruments supplier reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.05. LeMaitre Vascular had a return on equity of 10.57% and a net margin of 15.56%. The business had revenue of $53.48 million for the quarter, compared to analysts' expectations of $51.50 million. During the same period in the previous year, the firm posted $0.27 EPS. The business's revenue for the quarter was up 13.6% compared to the same quarter last year.May 3, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Price Target Raised to $77.00JMP Securities increased their price objective on shares of LeMaitre Vascular from $72.00 to $77.00 and gave the company a "market outperform" rating in a report on Friday.May 3, 2024 | markets.businessinsider.comKeyBanc Keeps Their Hold Rating on Lemaitre Vascular (LMAT)May 3, 2024 | markets.businessinsider.comOppenheimer Reaffirms Their Buy Rating on Lemaitre Vascular (LMAT)May 3, 2024 | finance.yahoo.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2024 Earnings Call TranscriptMay 3, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Arbutus Biopharma (ABUS), Lemaitre Vascular (LMAT)May 3, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Releases Q2 2024 Earnings GuidanceLeMaitre Vascular (NASDAQ:LMAT) updated its second quarter 2024 earnings guidance. The company provided EPS guidance of 0.450-0.500 for the period, compared to the consensus estimate of 0.440. The company also issued revenue guidance of $53.7 millionillion-$56.1 millionillion, compared to the consensus estimate of $54.3 millionillion.May 2, 2024 | investorplace.comLMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q1 2024May 2, 2024 | finance.yahoo.comLeMaitre Vascular Inc (LMAT) Q1 2024 Earnings: Surpasses Analyst Revenue ForecastsMay 2, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Releases FY24 Earnings GuidanceLeMaitre Vascular (NASDAQ:LMAT) updated its FY24 earnings guidance. The company provided EPS guidance of $1.73-1.84 for the period, compared to the consensus estimate of $1.65. The company also issued revenue guidance of $212.7-217.3 millionillion, compared to the consensus estimate of $211.69 millionillion.May 2, 2024 | globenewswire.comLeMaitre Q1 2024 Financial ResultsApril 27, 2024 | msn.comStifel Upgrades LeMaitre Vascular (LMAT)April 26, 2024 | markets.businessinsider.comBuy Rating Affirmed: LeMaitre Vascular’s Growth and Profitability OutlookApril 26, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Upgraded to "Buy" by Stifel NicolausStifel Nicolaus upgraded LeMaitre Vascular from a "hold" rating to a "buy" rating and increased their target price for the company from $59.00 to $75.00 in a report on Friday.April 19, 2024 | globenewswire.comLeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024April 19, 2024 | finance.yahoo.comLeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?April 18, 2024 | finance.yahoo.comLeMaitre Vascular, Inc. (LMAT)April 6, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Purchased by Vanguard Group Inc.Vanguard Group Inc. raised its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 2.3% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,510,567 shares of the medical instruApril 5, 2024 | finance.yahoo.comWhen Should You Buy LeMaitre Vascular, Inc. (NASDAQ:LMAT)?March 31, 2024 | marketbeat.comCopeland Capital Management LLC Has $71.52 Million Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Copeland Capital Management LLC lifted its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 2.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,259,961 shares of the medical inMarch 27, 2024 | benzinga.comEngaging In Options Activity, George LeMaitre Exercises Options Valued At $266K In LeMaitre VascularMarch 26, 2024 | globenewswire.comLeMaitre to Present at the 23rd Annual Needham Virtual Healthcare ConferenceMarch 22, 2024 | finance.yahoo.comInvesting in LeMaitre Vascular (NASDAQ:LMAT) five years ago would have delivered you a 137% gainMarch 17, 2024 | insidertrades.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Director Sells $344,925.00 in StockMarch 15, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Stock Rating Lowered by StockNews.comStockNews.com downgraded LeMaitre Vascular from a "buy" rating to a "hold" rating in a research report on Friday.March 8, 2024 | marketbeat.comGSA Capital Partners LLP Takes Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)GSA Capital Partners LLP bought a new position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 29,779 shares of the medical instruments suppliMarch 8, 2024 | finance.yahoo.comBe Sure To Check Out LeMaitre Vascular, Inc. (NASDAQ:LMAT) Before It Goes Ex-DividendMarch 5, 2024 | benzinga.comInsider Transaction: George LeMaitre Sells $6.94M Worth Of LeMaitre Vascular SharesMarch 4, 2024 | finance.yahoo.comLMAT Mar 2024 70.000 putMarch 2, 2024 | finance.yahoo.comLeMaitre Vascular's (NASDAQ:LMAT) Upcoming Dividend Will Be Larger Than Last Year'sMarch 2, 2024 | marketbeat.comEnvestnet Asset Management Inc. Purchases 38,958 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)Envestnet Asset Management Inc. boosted its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 24.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 195,983 shares of the medical instruments supplierMarch 2, 2024 | marketbeat.comQ1 2024 EPS Estimates for LeMaitre Vascular, Inc. Boosted by Analyst (NASDAQ:LMAT)LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) - Analysts at Barrington Research boosted their Q1 2024 earnings estimates for LeMaitre Vascular in a research note issued to investors on Wednesday, February 28th. Barrington Research analyst M. Petusky now forecasts that the medical instrument Get LeMaitre Vascular News Delivered to You Automatically Sign up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter. Email Address Must-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… LMAT Media Mentions By Week LMAT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LMAT News Sentiment▼0.920.42▲Average Medical News Sentiment LMAT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LMAT Articles This Week▼33▲LMAT Articles Average Week Get LeMaitre Vascular News Delivered to You Automatically Sign up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ATEC News IART News NVCR News MDXG News ATRC News AORT News ICUI News NARI News EMBC News ATRI News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LMAT) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyUrgent Nvidia WarningAltimetryShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDems have chosen Biden replacement?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LeMaitre Vascular, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
